Patient and external quality assessment samples demonstrate similar bias between manufacturers in titer of antibodies to nuclear antigens: Implications for commutability

Susan L. Fink, Michael A. Linden, Mark H. Wener

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)919-920
Number of pages2
JournalArchives of Pathology and Laboratory Medicine
Issue number8
StatePublished - Aug 1 2021

Bibliographical note

Funding Information:
Fink was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under awards K08AI119142, R21AI131269, and R21AI153487.

Cite this